Here Are the Early-Stage COVID Vaccine Stocks to Watch in 2021

Brian Orelli, PhD, The Motley Fool
·2-min read

Multiple biotechs have coronavirus vaccines with regulatory authorizations, and others are about to cross the finish line. In this video from Motley Fool Live, recorded on Jan. 4, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the potential benefits of the 2021 latecomers. Corinne Cardina: Looking a little sooner in the race, are there any coronavirus vaccine developers that are a little bit further behind that investors should be watching, and could have upcoming catalysts?